Actively Recruiting

Phase Not Applicable
Age: 21Years +
All Genders
NCT06409949

MitoQ Treatment of Claudication: Myofiber and Micro-vessel Pathology

Led by University of Nebraska · Updated on 2026-02-24

60

Participants Needed

1

Research Sites

208 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

In our research, we are delving into whether taking MitoQ for six months can improve the symptoms and function of people diagnosed with peripheral artery disease, especially those who suffer from leg pain while walking, known as intermittent claudication. We will be checking if MitoQ helps people with claudication walk better, be more active every day, feel better about their lives, and if it enhances the health of their leg muscles.

CONDITIONS

Official Title

MitoQ Treatment of Claudication: Myofiber and Micro-vessel Pathology

Who Can Participate

Age: 21Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Have a history of chronic claudication (leg pain when walking)
  • Exercise-limiting claudication confirmed by medical history and observed walking test by a vascular surgeon
  • Documented lower leg artery blockage shown by ankle/brachial index measurements or artery imaging
  • Stable blood pressure, cholesterol, and diabetes treatments and risk factor control for at least 6 weeks
Not Eligible

You will not qualify if you...

  • Presence of rest pain or tissue loss due to peripheral artery disease (Fontaine stage III or IV)
  • Recent acute lower leg ischemic event
  • Walking ability mainly limited by other conditions such as joint, musculoskeletal, neurological, heart, or lung diseases

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

VA Medical Center

Omaha, Nebraska, United States, 68105

Actively Recruiting

Loading map...

Research Team

H

Holly DeSpiegelaere, BSN RN CCRC

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

MitoQ Treatment of Claudication: Myofiber and Micro-vessel Pathology | DecenTrialz